Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Proteome Sciences Plc (PRM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7043
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Proteome Sciences Plc (Proteome Sciences) is a life sciences company that delivers content for personalized medicine through biomarkers, reagents and services. Its proteomics services include drug development, biomarker discovery and provision of data insights. It maps the protein expressions and modifications that help define processes for improving research outcomes. The company detects and characterizes deferentially expressed proteins using its proprietary technologies in biological samples for prognostic, diagnostic and therapeutic applications. The company develops novel biomarkers for various disease areas such as central nervous system diseases including Alzheimer’s, Huntington’s, stroke and traumatic brain injury; oncology comprising lung, breast, colorectal and esophageal cancers; and cardiac diseases, for diagnostic and treatment applications. It has facilities in London and Frankfurt. Proteome Sciences is headquartered in London, England, the UK.

Proteome Sciences Plc (PRM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Proteome Sciences Plc, Medical Equipment, Deal Details 10
Partnerships 10
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Equity Offering 13
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc – Key Competitors 17
Proteome Sciences Plc – Key Employees 18
Proteome Sciences Plc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 21
Financial Announcements 21
Jul 24, 2018: Proteome Sciences: Interim results for the six months ended 30 June 2018 21
Apr 24, 2018: Proteome Sciences: Preliminary results for the year ended 31 December 2017 24
Jul 25, 2017: Proteome Sciences: Interim Results for the Six Months Ended 30 June 2017 29
Mar 28, 2017: Proteome Sciences Announces Preliminary results for the year ended 31 December 2016 Notice of AGM 30
Corporate Communications 41
Apr 24, 2018: Proteome Sciences Appoints Richard Dennis As Board Director 41
Aug 01, 2017: Proteome Sciences: Directorate changes 42
Apr 03, 2017: Proteome Sciences Announces Appointment of Richard Dennis as Chief Commercial Officer 43
Legal and Regulatory 44
Oct 18, 2017: Proteome Sciences: GCLP Accreditation and Trading Update 44
Jun 12, 2017: Proteome Sciences: New Registered Address 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Proteome Sciences Plc, Medical Equipment, Key Facts, 2017 2
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Deals By Market, 2012 to YTD 2018 8
Proteome Sciences Plc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Randox Labs Enters Into Licensing Agreement With Proteome Sciences For Stroke Biomarker 10
Proteome Sciences Enters into Co-Development Agreement with Genting TauRx Diagnostic Centre 11
Proteome Sciences Enters Into Co-Development Agreement With Thermo Fisher 12
Proteome Sciences Raises USD1.3 Million in Second and Final Tranche of Private Placement of Shares 13
Proteome Sciences Raises USD2.8 Million in First Tranche of Private Placement of Shares 14
Proteome Sciences Announces Private Placement Of Shares For US$8.3 Million 15
Proteome Sciences Completes Private Placement Of Common Stock For US$2.4 Million 16
Proteome Sciences Plc, Key Competitors 17
Proteome Sciences Plc, Key Employees 18
Proteome Sciences Plc, Other Locations 19
Proteome Sciences Plc, Subsidiaries 19

List of Figures
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Proteome Sciences Plc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Proteome Sciences Plc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Proteome Sciences Plc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Proteome Sciences Plc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Proteome Sciences Plc (PRM):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …
  • Headwater Exploration Inc (HWX):企業の財務・戦略的SWOT分析
    Summary Headwater Exploration Inc (Headwater), formerly Corridor Resources Inc, is an oil and gas company. It is engaged in exploring, producing and developing of petroleum and natural gas products. The company’s core operating areas include McCully Field in New Brunswick, Anticosti Island in Quebec …
  • Lynntech Inc:企業の製品パイプライン分析
    Summary Lynntech Inc (Lynntech) is a diversified company. The company designs, fabricates and refines fuel cell test stations for research. It conducts research and development in the areas of energy, power, life sciences, materials science, therapeutics and diagnostics, chemical and environmental s …
  • Inova Health System:医療機器:M&Aディール及び事業提携情報
    Summary Inova Health System (Inova) is a non-profit health care delivery system. It owns owns, operates and manages several research, educational, clinical and hospital facilities. It offers home health and long term care services, joint replacement services, liver disease services, mental health se …
  • Silver Lake Resources Limited:企業の戦略・SWOT・財務情報
    Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Institute for Translational Vaccinology:製薬・医療:M&Aディール及び事業提携情報
    Summary Institute for Translational Vaccinology (Intravacc) is a nonprofit research and development organization that concentrates on the development of vaccines. The organization’s services include technology transfer, exploratory and clinical research and regulatory support. It also provides novel …
  • Takara Holdings Inc.:企業の戦略・SWOT・財務分析
    Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Takara Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rockwell Medical Inc (RMTI)-製薬・医療分野:企業M&A・提携分析
    Summary Rockwell Medical Inc (Rockwell) is a bio pharmaceutical company focusing on the development, manufacture and distribution of products and services for the treatment of iron deficiency, secondary hyperparathyroidism; end-stage renal disease (ESRD) and chronic kidney disease. Its major product …
  • Ameriprise Financial, Inc. (AMP):企業の財務・戦略的SWOT分析
    Ameriprise Financial, Inc. (AMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Rosinter Restaurants Holding Ojsc
    Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report Summary Rosinter Restaurants Holding Ojsc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Silver Peak Systems Inc:企業の戦略的SWOT分析
    Silver Peak Systems Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Slovnaft AS (1SLN01AE):企業の財務・戦略的SWOT分析
    Slovnaft AS (1SLN01AE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Maxeda B.V.:戦略・SWOT・企業財務分析
    Maxeda B.V. - Strategy, SWOT and Corporate Finance Report Summary Maxeda B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Almarai Company:企業の戦略・SWOT・財務情報
    Almarai Company - Strategy, SWOT and Corporate Finance Report Summary Almarai Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lonestar Resources US Inc (LONE):企業の財務・戦略的SWOT分析
    Lonestar Resources US Inc (LONE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Supreme Group B.V.:企業の戦略・SWOT・財務分析
    Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report Summary Supreme Group B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Tredegar Corp (TG):企業の財務・戦略的SWOT分析
    Tredegar Corp (TG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ogeda SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Ogeda SA (Ogeda), formerly Euroscreen SA, a subsidiary of Astellas Pharma Inc, is a clinical-stage drug discovery company that invents and develops fezolinetant and small molecule drugs targeting G-protein coupled receptors. The company discovers and develops drugs that treat hormone-depende …
  • Monsoon Accessorize Ltd:企業の戦略・SWOT・財務分析
    Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report Summary Monsoon Accessorize Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dynatronics Corp (DYNT):企業の財務・戦略的SWOT分析
    Summary Dynatronics Corp (Dynatronics) is a medical device company that offers physical therapy, aesthetics and medical products. The company offers hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and reha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆